tofacitinib and Lupus-Erythematosus--Discoid

tofacitinib has been researched along with Lupus-Erythematosus--Discoid* in 2 studies

Trials

1 trial(s) available for tofacitinib and Lupus-Erythematosus--Discoid

Article	Year
Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE). Journal of drugs in dermatology : JDD, 2023, 04-01, Volume: 22, Issue:4 Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098. Topics: Adult; Humans; Lupus Erythematosus, Discoid; Pilot Projects; Piperidines	2023

Article

Year

Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE).

Journal of drugs in dermatology : JDD, 2023, 04-01, Volume: 22, Issue:4

Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098.

Topics: Adult; Humans; Lupus Erythematosus, Discoid; Pilot Projects; Piperidines

2023

Other Studies

1 other study(ies) available for tofacitinib and Lupus-Erythematosus--Discoid

Article	Year
Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus. JAMA dermatology, 2021, 07-01, Volume: 157, Issue:7 Topics: Humans; Lupus Erythematosus, Discoid; Ointments; Piperidines; Pyrimidines	2021